Who owns Lumos Pharma Inc?
- Ticker: LUMO
- CUSIP Number: 55028x109
Tip: Access positions for across all investors
Analyze quarterly positions in Lumos Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Lumos Pharma stock
Who bought or sold Lumos Pharma Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Wells Fargo & Company | 417k | $1.3M | 0% | Dec 2023 |
|
Goldman Sachs Group | 407k | $1.3M | 0% | Dec 2023 |
|
Blackstone Group | 327k | $1.0M | -30% | Dec 2023 |
|
Vanguard Group | 244k | $776k | 4% | Dec 2023 |
|
Acuitas Investments | 125k | $394k | 0% | Dec 2023 |
|
Lion Point Capital | 91k | $289k | 0% | Dec 2023 |
|
Greenwich Wealth Management | 76k | $243k | 0% | Dec 2023 |
|
Two Sigma Investments | 43k | $136k | 100% | Dec 2023 |
|
Two Sigma Advisers | 28k | $90k | 100% | Dec 2023 |
|
Marquette Asset Management | 26k | $82k | 0% | Dec 2023 |
|
Private Advisor | 16k | $51k | -20% | Dec 2023 |
|
Dimensional Fund Advisors | 16k | $49k | 0% | Dec 2023 |
|
Bank of New York Mellon | 12k | $33k | 0% | Mar 2024 |
|
Wealth Advisors of Iowa | 12k | $37k | 0% | Dec 2023 |
|
Key FInancial | 11k | $35k | 0% | Dec 2023 |
|
Advisor Group Holdings | 4.6k | $15k | -40% | Dec 2023 |
|
Paladin Advisory Group | 4.4k | $14k | 0% | Dec 2023 |
|
Bank of America Corporation | 1.8k | $5.7k | 0% | Dec 2023 |
|
West Financial Advisors | 784.00 | $2.2k | 0% | Mar 2024 |
|
Cypress Capital Management | 100.00 | $318.000000 | 0% | Dec 2023 |
|
Royal Bank of Canada | 78.00 | $0 | -33% | Dec 2023 |
|
UBS Group | 74.00 | $235.001800 | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 38.00 | $119.000800 | 9% | Dec 2023 |
|
Global Retirement Partners | 11.00 | $31.000200 | 0% | Mar 2024 |
|
Live Oak Investment Partners | 11.00 | $34.999800 | 0% | Dec 2023 |
|